Results 171 to 180 of about 25,109 (253)

Antibody-Based Therapeutics in Breast Cancer: Clinical and Translational Perspectives. [PDF]

Antibodies (Basel)
Balata A, Pogoda K.
europepmc   +1 more source

Anti-HER3 Monoclonal Antibody GSK2849330 [PDF]

, 2020
openaire   +1 more source

Increased EGFR/HER2 Pathway Activation Contributes to Skin Tumorigenesis in <i>Tpl2</i>^-^/- Mice. [PDF]

Cancers (Basel)
Purkey LR, Mehedincu S, Irvine C, Akdag R, Little M, Kothmann WW, Rus K, Greenberg E, Shady N, DeCicco-Skinner K.   +9 more
europepmc   +1 more source

Optimization of HER3 expression imaging using affibody molecules: Influence of chelator for labeling with indium-111 [PDF]

, 2019
Sara S. Rinne, Charles Dahlsson Leitao, Bogdan Mitran, Tarek Bass, Karl Andersson, Vladimir Tolmachev, Stefan Ståhl, John Löfblom, Anna Orlova   +8 more
openalex   +1 more source

Trispecific eFab-eIg T-cell engagers targeting HER2 and HER3. [PDF]

Front Immunol
Löffler AK, Huber A, Olayioye MA, Kontermann RE, Seifert O.   +4 more
europepmc   +1 more source

TUXEDO-3: A phase 2 trial of patritumab deruxtecan for patients with leptomeningeal metastasis. [PDF]

Neuro Oncol
Le Rhun E, Franceschi E, Weller M.
europepmc   +1 more source

An updated review on systemic therapy for brain metastases in non-small cell lung cancer. [PDF]

Transl Cancer Res
Louis S, Aboubechara JP, Saigal K, Cao T, Nagpal S.   +4 more
europepmc   +1 more source

Advancements in Targeted Therapies for Colorectal Cancer: Overcoming Challenges and Exploring Future Directions. [PDF]

Cancers (Basel)
Khelwatty SA, Puvanenthiran S, Seddon AM, Bagwan I, Essapen S, Modjtahedi H.   +5 more
europepmc   +1 more source

Transcriptomic Profiling of the Tumor Microenvironment in High-Grade Serous Carcinoma: A Pilot Study of Morphologic and Molecular Distinctions Between Classic and SET Patterns. [PDF]

Int J Mol Sci
Giannini R, Bartoli F, Ieso K, Camacci T, Bertolucci A, Piccini L, Rreka E, Volterrani D, Gemignani F, Landi S, Ugolini C, Lippolis PV, Faviana P.   +12 more
europepmc   +1 more source

Deep sequencing combined with high-throughput screening enables efficient development of a pH-dependent high-affinity binding domain targeting HER3. [PDF]

Protein Sci
Möller M, Jönsson M, Lundqvist M, Rockberg J, Löfblom J, Tegel H, Hober S.   +6 more
europepmc   +1 more source